ATYs306Q6fE

82
W, Tomaselli G, Tracy C, Ackerman M, Belhassen B, Estes NA III, Fatkin D, Kalman
J, Kaufman E, Kirchhof P, Schulze-Bahr E, Wolpert C, Vohra J, Refaat M, Etheridge
SP, Campbell RM, Martin ET, Quek SC. Executive summary: HRS/EHRA/APHRS
expert consensus statement on the diagnosis and management of patients with
inherited primary arrhythmia syndromes. Europace. 2013;15:1389–406.
892. Antz M,Weiss C, Volkmer M, Hebe J, Ernst S, Ouyang F, Kuck KH. Risk of sudden
death after successful accessory atrioventricular pathway ablation in resuscitated
patients with Wolff-Parkinson-White syndrome. J Cardiovasc Electrophysiol.
2002;13:231–6.
893. Timmermans C, Smeets JL, Rodriguez LM, Vrouchos G, van den Dool A, Wellens
HJ. Aborted sudden death in the Wolff-Parkinson-White syndrome. Am J Cardiol.
1995;76:492–4.
894. Bromberg BI, Lindsay BD, Cain ME, Cox JL. Impact of clinical history and
electrophysiologic characterization of accessory pathways on management
strategies to reduce sudden death among children with Wolff-Parkinson-White
syndrome. J Am Coll Cardiol. 1996;27:690–5.
895. Al-Khatib SM, Arshad A, Balk EM, Das SR, Hsu JC, Joglar JA, Page RL. Risk
stratification for arrhythmic events in patients with asymptomatic preexcitation:
A systematic review for the 2015 ACC/AHA/HRS guideline for the
management of adult patients with supraventricular tachycardia: A Report of the
American College of Cardiology/American Heart Association Task Force on
Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm.
2016;13:e222–37.
896. Maron BJ, Ommen SR, Semsarian C, Spirito P, Olivotto I, Maron MS. Hypertrophic
cardiomyopathy: present and future, with translation into contemporary
cardiovascular medicine. J Am Coll Cardiol. 2014;64:83–99.
897. Robinson K, Frenneaux MP, Stockins B, Karatasakis G, Poloniecki JD, McKenna WJ.
Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study. J Am Coll
Cardiol. 1990;15:1279–85.
898. Mozaffarian D, Furberg CD, Psaty BM, Siscovick D. Physical activity and incidence
of atrial fibrillation in older adults: the cardiovascular health study. Circulation.
2008;118:800–7.
899. Elosua R, Arquer A, Mont L, Sambola A, Molina L, Garcia-Moran E, Brugada J,
Marrugat J. Sport practice and the risk of lone atrial fibrillation: a case-control
study. Int J Cardiol. 2006;108:332–7.
900. Mont L, Sambola A, Brugada J, Vacca M, Marrugat J, Elosua R, Pare C, Azqueta M,
Sanz G. Long-lasting sport practice and lone atrial fibrillation. Eur Heart J.
2002;23:477–82.
901. Abdulla J, Nielsen JR. Is the risk of atrial fibrillation higher in athletes than in the
general population? A systematic review and meta-analysis. Europace.
2009;11:1156–9.
902. Thelle DS, Selmer R, Gjesdal K, Sakshaug S, Jugessur A, Graff-Iversen S, Tverdal A,
NystadW. Resting heart rate and physical activity as risk factors for lone atrial
fibrillation: a prospective study of 309,540 men and women. Heart.
2013;99:1755–60.
903. Wilhelm M, Roten L, Tanner H, Wilhelm I, Schmid JP, Saner H. Atrial remodeling,
autonomic tone, and lifetime training hours in nonelite athletes. Am J Cardiol.
2011;108:580–5.
904. Guasch E, Benito B, Qi X, Cifelli C, Naud P, Shi Y, Mighiu A, Tardif JC, Tadevosyan
A, Chen Y, Gillis MA, Iwasaki YK, Dobrev D, Mont L, Heximer S, Nattel S. Atrial
fibrillation promotion by endurance exercise: demonstration and mechanistic
exploration in an animal model. J Am Coll Cardiol. 2013;62:68–77.
905. Andersen K, Farahmand B, Ahlbom A, Held C, Ljunghall S, Michaelsson K,
Sundstrom J. Risk of arrhythmias in 52 755 long-distance cross-country skiers:
a cohort study. Eur Heart J. 2013;34:3624–31.
906. Karjalainen J, Kujala UM, Kaprio J, Sarna S, Viitasalo M. Lone atrial fibrillation in
vigorously exercising middle aged men: case-control study. BMJ. 1998;316:1784–5.
907. Biffi A, Maron BJ, Culasso F, Verdile L, Fernando F, Di Giacinto B, Di Paolo FM,
Spataro A, Delise P, Pelliccia A. Patterns of ventricular tachyarrhythmias
associated with training, deconditioning and retraining in elite athletes without
cardiovascular abnormalities. Am J Cardiol. 2011;107:697–703.
908. Calvo N, Mont L, Tamborero D, Berruezo A, Viola G, Guasch E, Nadal M, Andreu D,
Vidal B, Sitges M, Brugada J. Efficacy of circumferential pulmonary vein ablation
of atrial fibrillation in endurance athletes. Europace. 2010;12:30–6.
909. Koopman P, Nuyens D, Garweg C, La Gerche A, De Buck S, Van Casteren L, Alzand
B, Willems R, Heidbuchel H. Efficacy of radiofrequency catheter ablation in
athletes with atrial fibrillation. Europace. 2011;13:1386–93.
910. Heidbuchel H, Panhuyzen-Goedkoop N, Corrado D, Hoffmann E, Biffi A, Delise P,
Blomstrom-Lundqvist C, Vanhees L, Ivarhoff P, Dorwarth U, Pelliccia A.
Recommendations for participation in leisure-time physical activity and
competitive sports in patients with arrhythmias and potentially arrhythmogenic
conditions Part I: Supraventricular arrhythmias and pacemakers. Eur J Cardiovasc
Prev Rehabil. 2006;13:475–84.
911. Silversides CK, Harris L, Haberer K, Sermer M, Colman JM, Siu SC. Recurrence
rates of arrhythmias during pregnancy in women with previous tachyarrhythmia
and impact on fetal and neonatal outcomes. Am J Cardiol. 2006;97:1206–12.
912. Salam AM, Ertekin E, van Hagen IM, Al Suwaidi J, Ruys TPE, Johnson MR,
Gumbiene L, Frogoudaki AA, Sorour KA, Iserin L, Ladouceur M, van Oppen ACC,
Hall R, Roos-Hesselink JW. Atrial Fibrillation or Flutter During Pregnancy in
Patients With Structural Heart Disease: Data From the ROPAC (Registry on
Pregnancy and Cardiac Disease). JACC Clin Electrophysiol. 2015;1:284–92.
913. Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield JE, Galie N,
Gatzoulis MA, Gohlke-Baerwolf C, Kaemmerer H, Kilner P, Meijboom F, Mulder BJ,
Oechslin E, Oliver JM, Serraf A, Szatmari A, Thaulow E, Vouhe PR, Walma E. ESC
Guidelines for the management of grown-up congenital heart disease (new
version 2010). Eur Heart J. 2010;31:2915–57.
914. Page RL. Treatment of arrhythmias during pregnancy. Am Heart J. 1995;130:
871–6.
915. Magee LA, Duley L. Oral beta-blockers for mild to moderate hypertension during
pregnancy. Cochrane Database Syst Rev. 2003;3:CD002863.
916. Mitani GM, Steinberg I, Lien EJ, Harrison EC, Elkayam U. The pharmacokinetics of
antiarrhythmic agents in pregnancy and lactation. Clin Pharmacokinet.
1987;12:253–91.
917. Gowda RM, Khan IA, Mehta NJ, Vasavada BC, Sacchi TJ. Cardiac arrhythmias in
pregnancy: clinical and therapeutic considerations. Int J Cardiol. 2003;88:129–
33.
918. Joint Formulary Committee. British National Formulary (online). http://www.
medicinescomplete.com (2 December 2014).
919. Bartalena L, Bogazzi F, Braverman LE, Martino E. Effects of amiodarone
administration during pregnancy on neonatal thyroid function and subsequent
neurodevelopment. J Endocrinol Invest. 2001;24:116–30.
920. Jaeggi ET, Carvalho JS, De Groot E, Api O, Clur SA, Rammeloo L, McCrindle BW,
Ryan G, Manlhiot C, Blom NA. Comparison of transplacental treatment of fetal
supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results
of a nonrandomized multicenter study. Circulation. 2011;124:1747–54.
921. Tromp CHN, Nanne ACM, Pernet PJM, Tukkie R, Bolte AC. Electrical cardioversion
during pregnancy: safe or not? Neth Heart J. 2011;19:134–6.
922. Ghosh N, Luk A, Derzko C, Dorian P, Chow CM. The acute treatment of maternal
supraventricular tachycardias during pregnancy: a review of the literature.
J Obstet Gynaecol Can. 2011;33:17–23.
923. Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO,
American College of Chest Physicians. VTE, thrombophilia, antithrombotic
therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis,
9 th ed: American College of Chest Physicians Evidence-Based Clinical Practice
Guidelines. Chest. 2012;141:e691S–736S.
924. Ahlsson AJ, Bodin L, Lundblad OH, Englund AG. Postoperative atrial fibrillation is
not correlated to C-reactive protein. Ann Thorac Surg. 2007;83:1332–7.
925. Arsenault KA, Yusuf AM, Crystal E, Healey JS, Morillo CA, Nair GM, Whitlock RP.
Interventions for preventing post-operative atrial fibrillation in patients
undergoing heart surgery. Cochrane Database Syst Rev. 2013;1:Cd003611.
926. Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, Barash PG, Hsu PH,
Mangano DT. A multicenter risk index for atrial fibrillation after cardiac surgery.
JAMA. 2004;291:1720–9.
927. Steinberg BA, Zhao Y, He X, Hernandez AF, Fullerton DA, Thomas KL, Mills R,
Klaskala W, Peterson ED, Piccini JP. Management of postoperative atrial
fibrillation and subsequent outcomes in contemporary patients undergoing
cardiac surgery: insights from the Society of Thoracic Surgeons CAPS-Care Atrial
Fibrillation Registry. Clin Cardiol. 2014;37:7–13.
928. Khan MF, Wendel CS, Movahed MR. Prevention of post-coronary artery bypass
grafting (CABG) atrial fibrillation: efficacy of prophylactic beta-blockers in the
modern era: a meta-analysis of latest randomized controlled trials. Ann
Noninvasive Electrocardiol. 2013;18:58–68.
929. Burgess DC, Kilborn MJ, Keech AC. Interventions for prevention of postoperative
atrial fibrillation and its complications after cardiac surgery: a meta-analysis. Eur
Heart J. 2006;27:2846–57.
930. Chatterjee S, Sardar P, Mukherjee D, Lichstein E, Aikat S. Timing and route of
amiodarone for prevention of postoperative atrial fibrillation after cardiac
surgery: a network regression meta-analysis. Pacing Clin Electrophysiol.
2013;36:1017–23.
931. Zhu J,Wang C, Gao D, Zhang C, Zhang Y, Lu Y, Gao Y. Meta-analysis of amiodarone
versus beta-blocker as a prophylactic therapy against atrial fibrillation following
cardiac surgery. Intern Med J. 2012;42:1078–87.
932. Fauchier L, Clementy N, Babuty D. Statin therapy and atrial fibrillation: systematic
review and updated meta-analysis of published randomized controlled trials.
Curr Opin Cardiol. 2013;28:7–18.
933. Zheng H, Xue S, Hu ZL, Shan JG, Yang WG. The use of statins to prevent
postoperative atrial fibrillation after coronary artery bypass grafting: a metaanalysis
of 12 studies. J Cardiovasc Pharmacol. 2014;64:285–92.
934. Zheng Z, Jayaram R, Jiang L, Emberson J, Zhao Y, Li Q, Du J, Guarguagli S, Hill M,
Chen Z, Collins R, Casadei B. Perioperative Rosuvastatin in Cardiac Surgery. N Engl
J Med. 2016;374:1744–53.
935. Cook RC, Yamashita MH, Kearns M, Ramanathan K, Gin K, Humphries KH.
Prophylactic magnesium does not prevent atrial fibrillation after cardiac surgery:
a meta-analysis. Ann Thorac Surg. 2013;95:533–541.
936. De Oliveira GS Jr, Knautz JS, Sherwani S, McCarthy RJ. Systemic magnesium to
reduce postoperative arrhythmias after coronary artery bypass graft surgery:
a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth.
2012;26:643–50.
937. Costanzo S, di Niro V, Di Castelnuovo A, Gianfagna F, Donati MB, de Gaetano G,
Iacoviello L. Prevention of postoperative atrial fibrillation in open heart surgery
patients by preoperative supplementation of n-3 polyunsaturated fatty acids: an
updated meta-analysis. J Thorac Cardiovasc Surg. 2013;146:906–11.
938. Farquharson AL, Metcalf RG, Sanders P, Stuklis R, Edwards JR, Gibson RA, Cleland
LG, Sullivan TR, James MJ, Young GD. Effect of dietary fish oil on atrial fibrillation
after cardiac surgery. Am J Cardiol. 2011;108:851–6.
939. Heidarsdottir R, Arnar DO, Skuladottir GV, Torfason B, Edvardsson V, Gottskalksson
G, Palsson R, Indridason OS. Does treatment with n-3 polyunsaturated fatty acids
prevent atrial fibrillation after open heart surgery? Europace. 2010;12:356–63.
940. Mariani J, Doval HC, Nul D, Varini S, Grancelli H, Ferrante D, Tognoni G, Macchia
A. N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated
systematic review and meta-analysis of randomized controlled trials. J Am Heart
Assoc. 2013;2:e005033.